Gupta R , Saito S , Mori Y , Itoh SG , Okumura H , Tominaga M .

	Figure 1. Species-specific differences in HC antagonism.(a,b) Representative traces of wt-hTRPA1 (a) or wt-fTRPA1 (b) currents in response to repeated CA application in X. laevis oocytes. (c,d) Representative traces showing that 50 μM HC inhibited CA-evoked currents in wt-hTRPA1 (c), but not in wt-fTRPA1 (d). (e,f) The differences in the inhibitory effects of HC (10, 25 and 50 μM) on CA-induced currents in oocytes expressing wt-hTRPA1 (e) or wt-fTRPA1 (f). Normalized current: ratio of the current amplitude in the second CA stimulation to that of the first with or without HC. (**P < 0.01), one way ANOVA post hoc Tukey test. Data are shown as the mean ± SEM. (e) wt-hTRPA1 (CA, n = 17; CA + 10 μM HC, n = 20; CA + 25 μM HC, n = 18; CA + 50 μM HC, n = 17). (f) wt-fTRPA1 (CA, n = 12; CA + 10 μM HC, n = 7; CA + 25 μM HC, n = 13; CA + 50 μM HC, n = 14).
	Figure 2. Effects of HC on various chimeric fTRPA1 and hTRPA1 channels.(a) Schematic representation of the hTRPA1 and fTRPA1 chimeras. hTRPA1 and fTRPA1 are depicted in grey and white, respectively. The regions of hTRPA1 included in the chimeras are indicated by brackets. (b–f) The effects of HC at different concentrations on the CA-evoked currents. Normalized current: ratio of the current amplitude in the second CA stimulation to that of the first with or without HC. (**P < 0.01), one way ANOVA post hoc Tukey test. Data are shown as the mean ± SEM. (b) F-H (T1-Ct) (0.3 mM CA, n = 11; CA + 10 μM HC, n = 9; CA + 25 μM HC, n = 9; CA + 50 μM HC, n = 10). (c) F-H (T1-T6)-F (0.5 mM CA, n = 16; CA + 10 μM HC, n = 6; CA + 25 μM HC, n = 12; CA + 50 μM HC, n = 11). (d) F-H (T3-Ct) (0.5 mM CA, n = 15; CA + 10 μM HC, n = 5; CA + 25 μM HC, n = 10; CA + 50 μM HC, n = 8). (e) F-H (T5-Ct) (0.2 mM CA, n = 7; CA + 10 μM HC, n = 5; CA + 25 μM HC, n = 7; CA + 50 μM HC, n = 8). (f) F-H (Ct) (0.1 mM CA, n = 12; CA + 10 μM HC, n = 5; CA + 25 μM HC, n = 5; CA + 50 μM HC, n = 13).
	Figure 3. Identification of the amino acid responsible for the inhibitory effects of HC on hTRPA1.(a) Amino acid alignment of the regions delineated by the chimeric analysis shown in Fig. 2. Amino acids were examined using the following formula: (human TRPA1 ≈ mouse TRPA1 ≈ green anole TRPA1 ≈ chicken TRPA1) ≠ (western clawed (WC) frog TRPA1); these differences are highlighted in black. The arrow indicates the amino acid involved in the inhibitory effect of HC. (b–d) Differences in the inhibitory effects of HC (b and c) or A96 (d) at different concentrations on CA-evoked currents in wt-hTRPA1 or hTRPA1-N855S. Normalized current: ratio of the current amplitude in the second CA stimulation to that of the first with or without HC. Each bar represents the mean ± SEM. (**P < 0.01), one way ANOVA post hoc Tukey test or t-test. (b) wt-hTRPA1 and hTRPA1-N855S (0.3 mM CA, n = 5,5; CA + 0.1 μM HC, n = 6,6; CA + 1 μM HC, n = 7,6; CA + 3 μM HC, n = 6,6; CA + 10 μM HC, n = 6,6; CA + 25 μM HC, n = 6,7; CA + 50 μM HC, n = 5,7). (c) wt-hTRPA1 and hTRPA1-N855S (0.3 mM CA, n = 11,11; CA + 0.1 μM A96, n = 4,5; CA + 1 μM A96, n = 4,5).
	Figure 4. Effects of HC on the hTRPA1-N855S mutant expressed in HEK293T cells.(a,b) The effects of HC (20 μM) on the CA (0.1 mM)-evoked increase in [Ca2+]i in HEK293 cells expressing wt-hTRPA1 or hTRPA1-N855S. Each bar represents the mean ± SEM. (*P < 0.05), t-test. (c) Comparison of the normalized ratio to the ionomycin responses between wt-hTRPA1 (n = 5 with and 5 without HC, respectively) and hTRPA1-N855S (n = 7 with and 7 without HC, respectively).
	Figure 5. HC inhibitory effects on fTRPA1 mutants.(a,b) Representative traces of CA (0.5 mM)-evoked currents in X. laevis oocytes expressing fTRPA1-S880N without (a) or with (b) HC (50 μM). (c,d) The effects of HC (c) or A96 (d) at different concentrations on CA-evoked currents in wt-fTRPA1 and fTRPA1-S880N. Normalized current: ratio of the current amplitude in the second CA stimulation to that of the first with or without HC. Each bar represents the mean ± SEM. (**P < 0.01), t-test. (c) (CA, n = 12,11; CA + 25 μM HC, n = 5,6; CA + 50 μM HC, n = 7,9). (d) (CA, n = 12,11; CA + 0.1 μM A96, n = 6,5; CA + 1 μM A96, n = 5,7).
	Figure 6. Effects of TRPA1 antagonists on zTRPA1b.(a) Comparison of N855 in hTRPA1 (asterisk) with that in mouse, chicken, green anole, western clawed (WC) frog, and zebrafish TRPA1. (b,c) Representative traces of CA-evoked currents in wt-zTRPA1b in the presence of 50 μM HC (b) or 1 μM A96 (c). (d,e) Effects of HC (d) or A96 (e) at different concentrations on CA (1 mM)-evoked wt-zTRPA1b currents. Normalized current: ratio of the current amplitude in the second CA stimulation to that of the first with or without HC. Each bar represents the mean ± SEM. (d) (CA, n = 18; CA + 10 μM HC, n = 11; CA + 25 μM HC, n = 11; CA + 50 μM HC, n = 13). (e) (CA, n = 18; CA + 0.1 μM A96, n = 10; CA + 1 μM A96, n = 10).
	Figure 7. Changes in the inhibitory effects of HC by a single point mutation in hTRPA1 and zTRPA1b.(a–d) Effects of HC (a,c) or A96 (b,d) at different concentrations on CA-evoked currents in wt-hTRPA1 and hTRPA1-N855R (a,b) or on the CA-evoked currents in wt-zTRPA1b and zTRPA1b-R860N (c,d). Normalized current: ratio of the current amplitude in the second CA stimulation to that of the first with or without HC. Each bar represents the mean ± SEM. (**P < 0.01, *P < 0.05), t-test. (a) wt-hTRPA1 and hTRPA1-N855R (0.3 mM CA, n = 9,9; CA + 25 μM HC, n = 8,8; CA + 25 μM HC, n = 7,8; CA + 50 μM HC, n = 7,8). (b) wt-hTRPA1 and hTRPA1-N855R (0.3 mM CA, n = 9,9; CA + 0.1 μM A96, n = 4,5; CA + 1 μM A96, n = 4,4). (c) wt-zTRPA1b and zTRPA1b-R860N (1 mM CA, n = 5,6; CA + 10 μM HC, n = 5,6; CA + 25 μM HC, n = 5,6; CA + 50 μM HC, n = 5,6). (d) wt-zTRPA1b and zTRPA1b-R860N (1 mM CA, n = 5,6; CA + 0.1 μM A96, n = 4,4; CA + 1 μM A96, n = 4,4).
	Figure 8. Effects of HC on point mutations in the C-terminal region of hTRPA1.(a) Amino acid alignment of the C-terminal regions of TRPA1 from different species. Amino acids were evaluated using the following formula: (human TRPA1 ≈ mouse TRPA1 ≈ green anole TRPA1 ≈ chicken TRPA1) ≠ (western clawed (WC) frog TRPA1); these differences are highlighted in black. (b) Effects of 50 μM HC on CA-evoked currents. Average normalized currents for CA with 50 μM HC were divided by the average normalized current for CA alone. For each mutant, n = 3–5.
	Figure 9. Synergistic interaction between N855 and the C-terminus of TRPA1 on the inhibitory effects of HC.(a,b) Representative traces of CA (0.1 mM)-evoked currents in X. laevis oocytes expressing the F-H (Ct) chimera with the fTRPA1-S880N mutation [F-H (Ct) + S880N] (a) or the F-H (Ct) chimera alone (b). (c,d) Effects of 50 μM HC on CA-evoked currents in the F-H (Ct) + S880N (a) or F-H (Ct) chimera alone (b). (e,f) Effects of HC (c) or A96 (d) at different concentrations on CA-evoked currents in the F-H (Ct) + S880N or F-H (Ct) chimera alone. Normalized current: ratio of the current amplitude in the second CA stimulation to that of the first with or without HC. Each bar represents the mean ± SEM. (**P < 0.01), t-test. (e) F-H (Ct) + fTRPA1-S880N and F-H (Ct) (0.1 mM CA, n = 12,12; CA + 0.1 μM HC, n = 6,4; CA + 1 μM HC, n = 5,5; CA + 3 μM HC, n = 6,4; CA + 10 μM HC, n = 9,8; CA + 25 μM HC, n = 9,9; CA + 50 μM HC, n = 9,9). (f) F-H (Ct) + fTRPA1-S880N and F-H (Ct) (0.1 mM CA, n = 8,8; CA + 1 μM A96, n = 3,3).
	Figure 10. Molecular dynamics simulation confirming the stable bond between HC and N855.(a) Snapshots of the MD simulation at 0 ns (left) and at 100 ns (right). The HC molecule and amino acid residue N855 are shown in a stick representation. These snapshots were rendered using the RasMol graphic software51. (b) A time series of the distance between the O atom of HC and the Hδ atom of N855 in the MD simulation. (c) Highlighted hydrophobic (green) and hydrophilic (purple) regions of the HC molecule.

Andrade, TRPA1 antagonists as potential analgesic drugs. 2012, Pubmed

Andrade, TRPA1 antagonists as potential analgesic drugs. 2012, Pubmed
Bandell, Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. 2004, Pubmed
Bang, Polymodal ligand sensitivity of TRPA1 and its modes of interactions. 2009, Pubmed
Banzawa, Molecular basis determining inhibition/activation of nociceptive receptor TRPA1 protein: a single amino acid dictates species-specific actions of the most potent mammalian TRPA1 antagonist. 2014, Pubmed
Bautista, TRPA1: A gatekeeper for inflammation. 2013, Pubmed
Cao, TRPV1 structures in distinct conformations reveal activation mechanisms. 2013, Pubmed
Cavanaugh, Activation of transient receptor potential A1 channels by mustard oil, tetrahydrocannabinol and Ca2+ reveals different functional channel states. 2008, Pubmed
Chen, Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation. 2011, Pubmed
Chen, Molecular determinants of species-specific activation or blockade of TRPA1 channels. 2008, Pubmed
Doerner, Transient receptor potential channel A1 is directly gated by calcium ions. 2007, Pubmed
Eid, HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. 2008, Pubmed
Gees, The role of transient receptor potential cation channels in Ca2+ signaling. 2010, Pubmed
Hinman, TRP channel activation by reversible covalent modification. 2006, Pubmed
Hoover, Canonical dynamics: Equilibrium phase-space distributions. 1985, Pubmed
Hornak, Comparison of multiple Amber force fields and development of improved protein backbone parameters. 2006, Pubmed
Kabsch, Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. 1983, Pubmed
Klement, Characterization of a ligand binding site in the human transient receptor potential ankyrin 1 pore. 2013, Pubmed , Xenbase
Klionsky, Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists. 2007, Pubmed
Kremeyer, A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. 2010, Pubmed
Martí-Renom, Comparative protein structure modeling of genes and genomes. 2000, Pubmed
McNamara, TRPA1 mediates formalin-induced pain. 2007, Pubmed
Morris, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. 2009, Pubmed
Mukhopadhyay, Expression of functional TRPA1 receptor on human lung fibroblast and epithelial cells. 2011, Pubmed
Nagatomo, The Met268Pro mutation of mouse TRPA1 changes the effect of caffeine from activation to suppression. 2010, Pubmed , Xenbase
Nagatomo, Caffeine activates mouse TRPA1 channels but suppresses human TRPA1 channels. 2008, Pubmed , Xenbase
Nakatsuka, Identification of molecular determinants for a potent mammalian TRPA1 antagonist by utilizing species differences. 2013, Pubmed , Xenbase
Okumura, Explicit symplectic integrators of molecular dynamics algorithms for rigid-body molecules in the canonical, isobaric-isothermal, and related ensembles. 2007, Pubmed
Okumura, Temperature and pressure denaturation of chignolin: folding and unfolding simulation by multibaric-multithermal molecular dynamics method. 2012, Pubmed
Okumura, Amyloid fibril disruption by ultrasonic cavitation: nonequilibrium molecular dynamics simulations. 2014, Pubmed
Paulsen, Structure of the TRPA1 ion channel suggests regulatory mechanisms. 2015, Pubmed
Petrus, A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. 2007, Pubmed , Xenbase
Prober, Zebrafish TRPA1 channels are required for chemosensation but not for thermosensation or mechanosensory hair cell function. 2008, Pubmed , Xenbase
Saito, Functional diversity and evolutionary dynamics of thermoTRP channels. 2015, Pubmed
Saito, Analysis of transient receptor potential ankyrin 1 (TRPA1) in frogs and lizards illuminates both nociceptive heat and chemical sensitivities and coexpression with TRP vanilloid 1 (TRPV1) in ancestral vertebrates. 2012, Pubmed , Xenbase
Saito, Heat and noxious chemical sensor, chicken TRPA1, as a target of bird repellents and identification of its structural determinants by multispecies functional comparison. 2014, Pubmed , Xenbase
Saito, Evolution of vertebrate transient receptor potential vanilloid 3 channels: opposite temperature sensitivity between mammals and western clawed frogs. 2011, Pubmed , Xenbase
Sayle, RASMOL: biomolecular graphics for all. 1995, Pubmed
Schwartz, Synergistic role of TRPV1 and TRPA1 in pancreatic pain and inflammation. 2011, Pubmed
Story, ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. 2003, Pubmed
Tamura, MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. 2011, Pubmed
Thompson, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. 1994, Pubmed
Wang, Development and testing of a general amber force field. 2004, Pubmed
Wang, The nociceptor ion channel TRPA1 is potentiated and inactivated by permeating calcium ions. 2008, Pubmed
Xiao, Identification of transmembrane domain 5 as a critical molecular determinant of menthol sensitivity in mammalian TRPA1 channels. 2008, Pubmed
Zíma, Structural modeling and patch-clamp analysis of pain-related mutation TRPA1-N855S reveal inter-subunit salt bridges stabilizing the channel open state. 2015, Pubmed